Transform® is fundamentally important to understanding and controlling the Covid-19 pandemic. It is currently powering three in-market rapid lateral flow tests in the UK, USA and Canada.

  • ISO13485
  • IEC62304
  • Fully GDPR Compliant
  • HIPAA Compliant

Controlling infection better with data

The ability to capture and report data in real time on Transform® means that the organisations using it – public health, workplaces, airports, universities and schools – can understand exactly what’s happening on the ground and take action quickly.

ISO 13485

We hold ISO 13485 certification, making Transform® a secure, regulatory compliant data management solution for lateral flow tests


We're British In Vitro Diagnostics Association members, and our Commercial Director Phil Groom leads BIVDA's digital working party

What Transform® does

Captures and manages results in real time

Use the Transform® app to capture test results and other data.

Makes real-time results visible via dashboards

Data is held securely on the cloud – where you can view it on dashboards.

Identifies hotspots

Pinpoint hotspots in real time – so you can act immediately.

Allows you to create reports

Stay in control – hone in on granular trends and run detailed reports.

Empowers you to keep spaces safe

Keep workplaces, schools, universities and transport hubs safe.

Complies with HIPAA and GDPR

Transform® complies with all patient data privacy standards – and is integrated with LOINC and SNOMED.

Key player in the fight against Covid-19

  • Part of NHS Wales Covid-19 consortium
  • Transform® launched as a COVID-19 Test and Track platform in Canada and the USA
  • Integrating Transform® with Lifepoint Informatics to allow Federal-level data collection
  • Partnering organisations to control Covid-19 in workplaces

Featured use case


I would recommend Bond because of the uncomplicated and clear structure you have. You know what you’re doing, you’re focussed on a certain field and have expertise in it.

Christian Fischer-Rasokat, Global Product Manager, QIAGEN Lake Constance

Partnering with Bond Digital Health has given a boost to Sona Nanotech, improving our value proposition by allowing us to offer an innovative and increasingly vital service to our customers, specifically a fully connected, secure, scalable and compliant digital system to enhance their tests.

Darren Rowles, Chief Scientific Officer and president of Sona Nanotech Inc. Canada.

Bond Digital Health has proven to be an incredibly responsive partner and very quickly demonstrated the ability to be a trusted supplier. They are a very important component to our approach and offering that will deliver significant value to our customers in the short, medium and long term.

Leigh Thomas, Senior VP, Director of Global Sales, Abingdon Health

Bond’s tireless efforts to fast-track the delivery of their Transform® platform has been outstanding.
Bond Digital Health is a great example of a technology business showing agility to adapt and accelerate where necessary, while still delivering a high quality, high-impact product.

David Dulieu, MediWales Innovation Awards Judge 2020 and Director of GS Verde Group

Bond is exactly the sort of partner we want, giving us a feeling of security as we develop the product together. This is important for us as we’re not IT experts. They’re a pleasure to work with: technically competent, highly responsive and operating with a can-do enthusiasm which is refreshing and infectious.

Chris Hunt, CEO, Microarray